For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use.
Menu
Reconstitution calculator

Neuropeptide research

Selank Dosage, Protocol & Research Guide

By Sam, MBA

  • MW 751.9 g/mol
  • CAS 129954-34-3
Dosage, protocol, reconstitution and storage reference for Selank, with a reconstitution calculator, vial sizes and cited research.

Dose overview

Every range below is taken from the cited source and carries its evidence grade.

No human dose-finding trial is cited on this page.

Animal data (context only, not a human dose)

Animal figures are shown for context and are never presented as a human dose. Use the converter to see how animal figures scale.

Animal data (context only, not a human dose)
SourceSpeciesDoseFrequencyRouteDurationEvidence
Naloxone-precipitated morphine withdrawal model (Bull Exp Biol Med 2022, doi 10.1007/s10517-022-05624-x)[2]single intraperitoneal injection of Selank 0.3 mg/kg, compared with diazepam 2 mg/kgrat (outbred)0.3 mg/kg[2]intraperitoneal; single injectionsingle injectionother— Animal or in-vitro study

Evidence grades: A approved label, B human trial, C observational, D animal study, E community-reported.

Reconstitution calculator

Sizes in the Pepcore catalogue10 mg

Calculator example, not a recommended amount

Concentration
2.5 mg/mL
Volume to draw
0.1 mL
Units on a U-100 syringe
10 units

0102030405060708090100

Properties

CAS
129954-34-3
Molecular weight
751.9 g/mol
Formula
Not yet recorded
Sequence
TKPRPGP
Aliases
TP-7, Selanc
Vial sizes (mg)
5, 10

Storage notes

Lyophilized
Not yet recorded from a cited source
Reconstituted stability (days)
Not yet recorded from a cited source

Side effects, contraindications and regulatory status

Reported side effects

  • FDA safety-risk page (current as of 04/22/2026), list of bulk drug substances nominated but withdrawn: FDA states it lacks important information on any safety issues raised by selank acetate administered to humans.[1] Regulator or expert-panel statement
  • FDA safety-risk page (current as of 04/22/2026) states compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration.[1] Regulator or expert-panel statement
  • Review authors describe selank as a poorly studied Russian drug with a GABAergic mechanism that is sold to US consumers as a dietary supplement (J Clin Pharmacol 2021).[5] Observational
  • Authors of a seized-product analysis state selank and semax, to their knowledge, have not completed any clinical trials, and call such research peptides potentially dangerous molecules (Drug Test Anal 2020).[6] Observational

Regulatory status

Listed in the 'nominated but withdrawn' table of the FDA bulk-substance safety-risk page (current 04/22/2026): selank acetate (TP-7); FDA lacks human safety information. Checked 2026-10-20.[1] Source

Report any adverse reaction to a qualified healthcare professional.

What the research says

Summaries of the cited studies, each with its evidence grade.

  • pubmed.ncbi.nlm.nih.gov[3]

    Human trial human

    Comparison of selank (30 patients) with medazepam (32 patients) in 62 patients with generalized anxiety disorder and neurasthenia (Zh Nevrol Psikhiatr 2008); dose, route and schedule are not printed in the abstract

    Human clinical trial

  • pubmed.ncbi.nlm.nih.gov[4]

    Human trial human

    Patients with generalized anxiety disorder and neurasthenia received selank for 14 days; serum Th1/Th2 cytokine balance was measured (Zh Nevrol Psikhiatr 2008); dose and route are not printed in the abstract

    Human clinical trial

  • Naloxone-precipitated morphine withdrawal model (Bull Exp Biol Med 2022, doi 10.1007/s10517-022-05624-x)[2]

    Animal study Animal data rat (outbred)

    Naloxone-precipitated morphine withdrawal model (Bull Exp Biol Med 2022, doi 10.1007/s10517-022-05624-x): single intraperitoneal injection of Selank 0.3 mg/kg, compared with diazepam 2 mg/kg

    Animal or in-vitro study

Compare vial sizes

Compare vial sizes
SizePriceDoses available from the vial CalculatedCost per dose Calculated
10 mg$37.99——

Cost per dose uses the listed partner price and the reference dose cited on this page. Prices change; check the product page.

Calculated from a default of 2 mL water (adjustable).

PeptideCheck may earn a commission when you use Pepcore links, at no extra cost to you. Read the disclosure.

Frequently asked questions

Is there a human dose figure for Selank on this page?

No human dose figure is cited on this page. The cited research is in animals (evidence grade D); it is shown separately and is not a human dose.

What is the regulatory status of Selank?

Listed in the 'nominated but withdrawn' table of the FDA bulk-substance safety-risk page (current 04/22/2026): selank acetate (TP-7); FDA lacks human safety information. Checked 2026-10-20.

Compound facts

Recorded molecular weight: 751.9 g/mol.
Recorded CAS number: 129954-34-3
Not yet recorded from a cited source.

Sources

https://pubchem.ncbi.nlm.nih.gov/compound/11765600
PubMed IDs
31625062, 32342318

References

Numbered sources used on this page. Markers in the text link here.

  1. fda.gov Regulator or expert-panel statement
  2. Naloxone-precipitated morphine withdrawal model (Bull Exp Biol Med 2022, doi 10.1007/s10517-022-05624-x) pubmed.ncbi.nlm.nih.gov Animal study
  3. pubmed.ncbi.nlm.nih.gov Human trial
  4. pubmed.ncbi.nlm.nih.gov Human trial
  5. pubmed.ncbi.nlm.nih.gov Observational
  6. pubmed.ncbi.nlm.nih.gov Observational

Vial sizes and protocols

  • 10 mgPartner size

Available from Pepcore

Supplied as research material for laboratory use only.

  • Selank Research Material - 10mg 10 mg$37.99
    Shop at PepcoreCoupon code LAUNCH20

PeptideCheck may earn a commission when you use Pepcore links, at no extra cost to you. Read the disclosure.